SUNPHARMA.NS vs. CIPLA.NS
Compare and contrast key facts about Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Cipla Limited (CIPLA.NS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SUNPHARMA.NS or CIPLA.NS.
Correlation
The correlation between SUNPHARMA.NS and CIPLA.NS is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SUNPHARMA.NS vs. CIPLA.NS - Performance Comparison
Key characteristics
SUNPHARMA.NS:
0.44
CIPLA.NS:
0.11
SUNPHARMA.NS:
0.73
CIPLA.NS:
0.36
SUNPHARMA.NS:
1.09
CIPLA.NS:
1.04
SUNPHARMA.NS:
0.56
CIPLA.NS:
0.16
SUNPHARMA.NS:
1.37
CIPLA.NS:
0.33
SUNPHARMA.NS:
6.16%
CIPLA.NS:
7.89%
SUNPHARMA.NS:
19.27%
CIPLA.NS:
24.23%
SUNPHARMA.NS:
-71.46%
CIPLA.NS:
-86.45%
SUNPHARMA.NS:
-15.14%
CIPLA.NS:
-12.31%
Fundamentals
SUNPHARMA.NS:
₹3.94T
CIPLA.NS:
₹1.19T
SUNPHARMA.NS:
₹47.74
CIPLA.NS:
₹61.70
SUNPHARMA.NS:
34.43
CIPLA.NS:
23.92
SUNPHARMA.NS:
₹513.64B
CIPLA.NS:
₹268.70B
SUNPHARMA.NS:
₹317.10B
CIPLA.NS:
₹137.87B
SUNPHARMA.NS:
₹161.31B
CIPLA.NS:
₹75.68B
Returns By Period
In the year-to-date period, SUNPHARMA.NS achieves a -12.34% return, which is significantly lower than CIPLA.NS's -3.51% return. Over the past 10 years, SUNPHARMA.NS has underperformed CIPLA.NS with an annualized return of 7.06%, while CIPLA.NS has yielded a comparatively higher 8.86% annualized return.
SUNPHARMA.NS
-12.34%
-8.63%
-6.88%
6.47%
34.27%
7.06%
CIPLA.NS
-3.51%
2.49%
-6.38%
2.79%
28.88%
8.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SUNPHARMA.NS vs. CIPLA.NS — Risk-Adjusted Performance Rank
SUNPHARMA.NS
CIPLA.NS
SUNPHARMA.NS vs. CIPLA.NS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Cipla Limited (CIPLA.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SUNPHARMA.NS vs. CIPLA.NS - Dividend Comparison
SUNPHARMA.NS's dividend yield for the trailing twelve months is around 0.94%, more than CIPLA.NS's 0.88% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SUNPHARMA.NS Sun Pharmaceutical Industries Limited | 0.94% | 0.72% | 0.91% | 1.00% | 0.89% | 0.68% | 0.64% | 0.46% | 0.61% | 0.16% | 0.37% | 0.18% |
CIPLA.NS Cipla Limited | 0.88% | 0.85% | 0.68% | 0.46% | 0.53% | 0.37% | 0.63% | 0.58% | 0.33% | 0.35% | 0.31% | 0.32% |
Drawdowns
SUNPHARMA.NS vs. CIPLA.NS - Drawdown Comparison
The maximum SUNPHARMA.NS drawdown since its inception was -71.46%, smaller than the maximum CIPLA.NS drawdown of -86.45%. Use the drawdown chart below to compare losses from any high point for SUNPHARMA.NS and CIPLA.NS. For additional features, visit the drawdowns tool.
Volatility
SUNPHARMA.NS vs. CIPLA.NS - Volatility Comparison
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Cipla Limited (CIPLA.NS) have volatilities of 7.64% and 7.80%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SUNPHARMA.NS vs. CIPLA.NS - Financials Comparison
This section allows you to compare key financial metrics between Sun Pharmaceutical Industries Limited and Cipla Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities